TRBV5-4 (TCRBV5S6A3N2T): A Potential Drug Target and Biomarker

Target Name: TRBV5-4

NCBI ID: G28611

TRBV5-4

Other Name(s): TCRBV5S6A3N2T | TRBV54 | TCRBV5S4 | T cell receptor beta variable 5-4

TRBV5-4 (TCRBV5S6A3N2T): A Potential Drug Target and Biomarker

Abstract:

TRBV5-4 (TCRBV5S6A3N2T), a small molecule derived from the tricalcium alkaline phosphatase (TALP) gene, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. This compound has been shown to induce apoptosis in various cell types, including cancer cells, and to promote the production of pro-inflammatory cytokines. In this article, we will discuss the structures and functions of TRBV5-4, its potential drug targeting implications, and its potential as a biomarker for various diseases.

Introduction:

Alkaline phosphatase (ALP) enzymes are a group of transmembrane proteins that are involved in a wide range of physiological processes, including bone and tissue development, nerve function, and cell signaling. One of the most well-known ALP enzymes is tricalcium alkaline phosphatase ( TALP), which is expressed in various tissues and is involved in the regulation of calcium homeostasis. TALP has been implicated in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

TRBV5-4, a small molecule derived from the TALP gene, has been shown to have a wide range of physiological effects, including the regulation of cell apoptosis, inflammation, and cellular signaling. In this article, we will focus on the potential drug targeting implications of TRBV5-4 and its potential as a biomarker for various diseases.

Structure and Function of TRBV5-4:

TRBV5-4 is a small molecule that is derived from the TALP gene. It consists of a 21-amino acid residue protein fragment that is capable of inducing apoptosis in various cell types, including cancer cells. The molecular weight of TRBV5-4 is approximately 18kDa.

The TRBV5-4 protein has been shown to induce apoptosis in various cell types, including cancer cells. This is achieved by the formation of a cation-in the cytosol, which eventually leads to the formation of a conglomerate of linear chains, resulting in the death of the cell.

In addition to its ability to induce apoptosis, TRBV5-4 has also been shown to promote the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and interleukin -6 (IL-6). These cytokines have been shown to play important roles in the development and progression of various diseases, including cancer.

Potential Drug Targeting Implications:

The ability of TRBV5-4 to induce apoptosis and promote the production of pro-inflammatory cytokines makes it a potential drug target for various diseases. One of the primary goals of drug development is to identify compounds that can inhibit the effects of TRBV5-4 and prevent its development as a drug target.

TRBV5-4 has also been shown to be effective in inhibiting the production of pro-inflammatory cytokines, making it a potential drug candidate for the treatment of various inflammatory diseases, including cancer. Additionally, TRBV5-4 has also been shown to be effective in inhibiting the induce

Protein Name: T Cell Receptor Beta Variable 5-4

Functions: V region of the variable domain of T cell receptor (TR) beta chain that participates in the antigen recognition (PubMed:24600447). Alpha-beta T cell receptors are antigen specific receptors which are essential to the immune response and are present on the cell surface of T lymphocytes. Recognize peptide-major histocompatibility (MH) (pMH) complexes that are displayed by antigen presenting cells (APC), a prerequisite for efficient T cell adaptive immunity against pathogens (PubMed:25493333). Binding of alpha-beta TR to pMH complex initiates TR-CD3 clustering on the cell surface and intracellular activation of LCK that phosphorylates the ITAM motifs of CD3G, CD3D, CD3E and CD247 enabling the recruitment of ZAP70. In turn ZAP70 phosphorylates LAT, which recruits numerous signaling molecules to form the LAT signalosome. The LAT signalosome propagates signal branching to three major signaling pathways, the calcium, the mitogen-activated protein kinase (MAPK) kinase and the nuclear factor NF-kappa-B (NF-kB) pathways, leading to the mobilization of transcription factors that are critical for gene expression and essential for T cell growth and differentiation (PubMed:23524462). The T cell repertoire is generated in the thymus, by V-(D)-J rearrangement. This repertoire is then shaped by intrathymic selection events to generate a peripheral T cell pool of self-MH restricted, non-autoaggressive T cells. Post-thymic interaction of alpha-beta TR with the pMH complexes shapes TR structural and functional avidity (PubMed:15040585)

The "TRBV5-4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRBV5-4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets